跳至主要内容
临床试验/CTRI/2022/02/040117
CTRI/2022/02/040117尚未招募3 期

Efficacy of Agnikarma with Panchadhatu Shalaka & Agnikarma with Electrocautery in the Management of Janusandhigata Vata (Osteoarthritis of Knee Joint) – An Open Labelled Randomized Comparative Clinical Trial

ITRA1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2022年2月15日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
relief in sign and symptoms

研究概览

简要总结

The presenr clinical trial is an open labelled randomized control clinical trial on Janusandhigata Vata (O.A. Knee).In this study total 30 patients will be registered and divided into 2 groups with minimum 15 patients in each group. The interventional group A will receive Agnikarma by Panchadhatu Shalaka and group B will receive Agnikarma by Electrocautery. Total duration of study is 4 weeks with follow up after 8 weeks.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
40.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Patients suffering from Janusandhigata Vata (O.A. of knee joint) Patient indicated for Agnikarma as per classics (severe pain at Janusandhi).

排除标准

  • Patients of Diabetes mellitus, R.A. (Rheumatoid Arthritis) positive, Gouty arthritis, Gross Knee Joint Effusion.
  • Other Diseases like Paralysis, Parkinson’s disease, cardiac diseases, pacemaker in situ, renal diseases and endocrine diseases, severe Anemia, and malignancy.
  • Pregnant and Lactating females.
  • Known cases of secondary O.A. due to T.B., Syphilis, AIDS, Leprosy etc.
  • Patients contraindicated for Agnikarma as per classics-Pitta Prakruti Rogi, Durbala (weak), Bheeru (afraid), Sharad and Grishma Ritu.

结局指标

主要结局

relief in sign and symptoms

时间窗: assess after 4 weeks

次要结局

  • Increase quality of life style(12 weeks)

研究者

发起方
ITRA
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验